|
Serotype
|
No. of strains (total/biofilm producers)a
|
|---|
| |
Patients
|
Controls
|
Total
|
|---|
|
EPEC serotypes
| | | |
| |
O26:H11;HND
|
9/2
|
1/0
|
10/2
|
| |
O55:HND
|
4/1
|
1/0
|
5/1
|
| |
O111:NM
|
2/1
|
2/1
|
4/2
|
| |
O114:NM
|
0
|
1/0
|
1/0
|
| |
O119:H2;HND
|
9/4
|
1/0
|
10/4
|
| |
O125:HND
|
0
|
1/0
|
1/0
|
| |
O126:NM
|
1/1
|
0
|
1/1
|
| |
O127:NM;H40
|
4/2
|
1/0
|
5/2
|
| |
O128:NM
|
2/0
|
0
|
2/0
|
| |
O142:NM;H2
|
10/1
|
0
|
10/1
|
|
Non-EPEC serotypesb
|
23/5
|
12/2
|
35/7
|
|
ONT:H18/NM; HND
|
28/15
|
14/2
|
42/17
|
|
Total
|
92/32
|
34/5c
|
126/37
|
-
aBiofilm assays were performed in 96-well polystyrene microtiter plates in Luria broth and incubated for 24 h at 26°C and 37°C.
-
bO4:HND; O15:HND O33:H6; O35:H19; O37:HND; O49:HND; O61:HND; O63:HND; O79:HND; O85:H40; O96:HND; O98:HND; O101:HNM; O103:HNM; O105:H7; O108:H31; O109:H54; O117:HND; 0132:HND; O141:HND; O1523H2; O156:H16; O157:NM; O167:H6; O169:H6; O175:HND.
-
CP < 0.05 (patients x controls).
